Skip to main content

Cardio-Oncology

Ausgabe 1/2020

Inhalt (31 Artikel)

Open Access Research

Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin

Jieli Li, Hui-Ming Chang, Jose Banchs, Dejka M. Araujo, Saamir A. Hassan, Elizabeth A. Wagar, Edward T. H. Yeh, Qing H. Meng

Open Access Short communication

Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy

Justin M. Canada, Georgia K. Thomas, Cory R. Trankle, Salvatore Carbone, Hayley Billingsley, Benjamin W. Van Tassell, Ronald K. Evans, Ryan Garten, Elisabeth Weiss, Antonio Abbate

Open Access Research

Hospitalized cancer patients with acquired long QT syndrome-a matched case-control study

Yajuan Lin, Haixu Yu, Fei Liu, Cheng Chen, Yanli Zhang, Binhao Wang, Yiheng Yang, Ying Liu, Li Zhang, Yunlong Xia

Open Access Short communication

A case report: high dose melphalan as a conditioning regimen for multiple myeloma induces sinus arrest

Liang-Liang Ma, Ying Liu, Si-Xun Jia, Hai-Chen Lv, Mei-Yun Fang, Yun-Long Xia

Open Access Research

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy

Timothy N. McOwan, Lauren A. Craig, Anne Tripdayonis, Kathy Karavendzas, Michael M. Cheung, Enzo R. Porrello, Rachel Conyers, David A. Elliott

Open Access Research

Cardiac MRI utilizing late gadolinium enhancement (LGE) and T1 mapping in the detection of radiation induced heart disease

Anthony Ricco, Alexander Slade, Justin M. Canada, John Grizzard, Franklin Dana, Leila Rezai Gharai, Keith Neiderer, Armando Vera, Antonio Abbate, Elisabeth Weiss

Open Access Research

The hypertensive effect of sorafenib is abolished by sildenafil

Hubert Dabiré, Fatou Dramé, Nelly Cita, Bijan Ghaleh

Open Access Research

Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: a systematic review and meta-analysis

Meer Rabeel Zafar, Syed Farrukh Mustafa, Timothy W. Miller, Talal Alkhawlani, Umesh C. Sharma

Open Access Research

Practical and cost-effective model to build and sustain a cardio-oncology program

Diego Sadler, Chakra Chaulagain, Beatrice Alvarado, Robert Cubeddu, Elizabeth Stone, Thomas Samuel, Bruno Bastos, David Grossman, Chieh-Lin Fu, Evan Alley, Arun Nagarajan, Timmy Nguyen, Wesam Ahmed, Leah Elson, Zeina Nahleh

Open Access Research

Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction

Maria Isabel Camara Planek, Ahmad Manshad, Kyaw Hein, Mohamad Hemu, Fatima Ballout, Rajiv Varandani, Parameswaran Venugopal, Tochukwu Okwuosa

Open Access Research

Quantitative assessment of cardiovascular autonomic impairment in cancer survivors: a single center case series

Benjamin Noor, Shannel Akhavan, Michael Leuchter, Eric H. Yang, Olujimi A. Ajijola

Open Access Research

Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin’s lymphoma: a systematic review

Yaser Khalid, Michael Fradley, Neethi Dasu, Kirti Dasu, Ankit Shah, Adam Levine

Open Access Research

Atlas-based measures of left ventricular shape may improve characterization of adverse remodeling in anthracycline-exposed childhood cancer survivors: a cross-sectional imaging study

Hari K. Narayan, Ronghui Xu, Nickolas Forsch, Sachin Govil, David Iukuridze, Lanie Lindenfeld, Eric Adler, Sanjeet Hegde, Adriana Tremoulet, Bonnie Ky, Saro Armenian, Jeffrey Omens, Andrew D. McCulloch

Open Access Short communication

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series

Mishita Goel, Rajiv Sunil Varandani, Tochukwu M. Okwuosa

Open Access Research

Approaches to management of cardiovascular morbidity in adult cancer patients – cross-sectional survey among cardio-oncology experts

E. Hedayati, A. Papakonstantinou, A. Månsson-Broberg, J. Bergh, L. Hubbert, R. Altena

Open Access Short communication

Carfilzomib induced cardiotoxicity in a multiple myeloma patient

Arnold Méndez-Toro, Cándida Díaz-Brochero, Estivalis Acosta-Gutiérrez

Open Access Short communication

Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report

Taku Yasui, Yohei Okuda, Wataru Shioyama, Toru Oka, Tatsuya Nishikawa, Risa Kamada, Koji Hatano, Kazuo Nishimura, Masashi Fujita

Open Access Short communication

#CardioOncology: Twitter chat as a mechanism for increasing awareness of heart health for cancer patients

Claire C. Conley, Neha G. Goyal, Sherry-Ann Brown

Open Access Research

Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series

Puja Arora, Laura Talamo, Patrick Dillon, Ryan D. Gentzler, Trish Millard, Michael Salerno, Craig L. Slingluff Jr, Elizabeth M. Gaughan

Open Access Review

A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma

Nway Le Ko Ko, Nareg Minaskeian, Hicham Z. El Masry

Open Access Research

Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy

Janine A. M. Kamphuis, Marijke Linschoten, Maarten J. Cramer, Pieter A. Doevendans, Folkert W. Asselbergs, Arco J. Teske

Open Access Research

Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Vanesa Gregorietti, Teresa Lopez Fernandez, Diego Costa, Elías Ortega Chahla, Andrés J. Daniele

Open Access Short communication

In ®Entresto we trust

Massimiliano Camilli, Marco Giuseppe Del Buono, Pierantonio Menna, Giorgio Minotti

Open Access Research

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer

Sagar Sardesai, Jasmine Sukumar, Mahmoud Kassem, Marilly Palettas, Julie Stephens, Evan Morgan, Daniel Addison, Ragavendra Baliga, Daniel G. Stover, Jeffrey VanDeusen, Nicole Williams, Mathew Cherian, Maryam Lustberg, Robert Wesolowski, Bhuvaneswari Ramaswamy

Open Access Short communication

Aerobic and resistance exercise improves Reynolds risk score in overweight or obese breast cancer survivors

Kyuwan Lee, Nathalie Sami, Debu Tripathy, Wendy Demark-Wahnefried, Mary K. Norris, Kerry S. Courneya, Christina M. Dieli-Conwright

Open Access Research

Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey

Diego Sadler, Jeanne M. DeCara, Joerg Herrmann, Anita Arnold, Arjun K. Ghosh, Husam Abdel-Qadir, Eric H. Yang, Sebastian Szmit, Nausheen Akhter, Monika Leja, Carolina Maria Pinto Domingues Carvalho Silva, Jayant Raikhelkar, Sherry-Ann Brown, Susan Dent, Rupal O’Quinn, Franck Thuny, Rohit Moudgil, Luis E. Raez, Tochukwu Okwuosa, Andres Daniele, Brenton Bauer, Lavanya Kondapalli, Roohi Ismail-Khan, Jorge Lax, Anne Blaes, Zeina Nahleh, Leah Elson, Lauren A. Baldassarre, Vlad Zaha, Vijay Rao, Daniel Sierra Lara, Kerry Skurka

Open Access Research

The prevalence of iron deficiency and anemia and their impact on survival in patients at a cardio-oncology clinic

E. Čiburienė, J. Čelutkienė, S. Aidietienė, G. Ščerbickaitė, A. R. Lyon

Open Access Short communication

Takotsubo syndrome induced by brachytherapy in a patient with endocervical adenocarcinoma

Aline Cristini Vieira, Mauricio Fernando Silva Almeida Ribeiro, Julianne Lima, Jacob Sessim Filho, Heloisa de Andrade Carvalho, Max Senna Mano

Open Access Short communication

A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene)

Sean DeAngelo, Kailyn I. Mann, Muhammad Abdulbasit, Amy Ahnert, Deborah W. Sundlöf

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.